A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE1
Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
- Status
- COMPLETED
- Phase
- PHASE1
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Status
- RECRUITING
- Phase
- PHASE2
Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations
- Status
- UNKNOWN
- Phase
- PHASE1
PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
- Status
- RECRUITING
- Phase
- PHASE2
GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab
- Status
- WITHDRAWN
- Phase
- PHASE1
7T MRI Scan for the Early Detection of Melanoma Brain Metastases
- Status
- TERMINATED
- Phase
- NA
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
- Status
- WITHDRAWN
- Phase
- NA
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1